Patients with lupus have lower utilization in HMOs
For care delivered in HMO settings to be effective, patients with chronic diseases as well as healthy individuals should receive appropriate care from the appropriate providers at the appropriate times. In a study by researchers at the University of California, San Francisco (UCSF)1, patients with systemic lupus erythematosus (SLE) enrolled in HMOs had lower use of outpatient physician visits and less use of diagnostic testing, along with fewer outpatient surgeries and hospital admissions, than those enrolled in FFS health plans. Although providing the proper primary and preventive care often results in lower healthcare utilization and cost, the relationship between utilization and outcomes in complex SLE patients is more tenuous.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- PCI: Concerns Mount About Appropriateness
- Transforming Cancer Care
- MA an Insurance Proving Ground for Providers
- mHealth Tackles Readmissions